alutard
Biologicalexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2010 (NCT01085526)
Timeline
2020s
- Jan 1, 2025
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetImmunity, desensitized
allergen
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- alutard
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06960382 | Phase 1/Phase 2 (Phase 2) | Aug 26, 2025 | University of Zurich |
| NCT01085526 | N/A | Feb 1, 2010 | Aarhus University, ALK-Abello, S.A., Lundbeck |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Aarhus University | Academic/Hospital | 1 | 1 | 1 | 2010 |
| ALK-Abello, S.A. | For profit | 1 | 0 | 1 | 2010 |
| Lundbeck | For profit | 1 | 0 | 1 | 2010 |
| University of Zurich | Academic/Hospital | 1 | 1 | 1 | 2025 |
4 organizations
Page 1 / 1